Jenburkt Pharmaceuticals | JENBURKT | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
204
253
266
211
165
Cash flow Operating Act...
Cash flow Operating Activities
98162130150195
Investments in PPE
Investments in PPE
-4-5-24-46-11
Cash flow Investing Act...
Net cash used for Investment Activities
2010-105-29-188
Dividend Paid
Dividend Paid
077201031
Cash flow Financing Act...
Net cash provided by Financing Activities
6-180-24-108-7
Cash at beginning of period
Cash at beginning of period
29620121225
Cash at end of period
Cash at end of period
42112122525
Free Cash Flow
Free Cash Flow
95
157
106
105
183